BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31253400)

  • 1. Protein phosphatase 1 of Leishmania donovani exhibits conserved catalytic residues and pro-inflammatory response.
    Qureshi R; Jakkula P; Sagurthi SR; Qureshi IA
    Biochem Biophys Res Commun; 2019 Aug; 516(3):770-776. PubMed ID: 31253400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania donovani PP2C: Kinetics, structural attributes and in vitro immune response.
    Jakkula P; Qureshi R; Iqbal A; Sagurthi SR; Qureshi IA
    Mol Biochem Parasitol; 2018 Jul; 223():37-49. PubMed ID: 29964060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmanial aspartyl-tRNA synthetase: Biochemical, biophysical and structural insights.
    Panigrahi GC; Qureshi R; Jakkula P; Kumar KA; Khan N; Qureshi IA
    Int J Biol Macromol; 2020 Dec; 165(Pt B):2869-2885. PubMed ID: 33736288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response.
    Singh MK; Jamal F; Dubey AK; Shivam P; Kumari S; Pushpanjali ; Bordoloi C; Narayan S; Das VNR; Pandey K; Das P; Singh SK
    Cytokine; 2019 Jan; 113():200-215. PubMed ID: 30001865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Leishmania donovani histidine acid ecto-phosphatase LdMAcP: insight into its structure and function.
    Papadaki A; Politou AS; Smirlis D; Kotini MP; Kourou K; Papamarcaki T; Boleti H
    Biochem J; 2015 May; 467(3):473-86. PubMed ID: 25695743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages.
    Privé C; Descoteaux A
    Eur J Immunol; 2000 Aug; 30(8):2235-44. PubMed ID: 10940915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning, biochemical and structural analysis of elongation factor-1 alpha from Leishmania donovani: comparison with the mammalian homologue.
    Nandan D; Cherkasov A; Sabouti R; Yi T; Reiner NE
    Biochem Biophys Res Commun; 2003 Mar; 302(4):646-52. PubMed ID: 12646217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production.
    Forget G; Gregory DJ; Whitcombe LA; Olivier M
    Infect Immun; 2006 Nov; 74(11):6272-9. PubMed ID: 17057094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of calreticulin P-domain results in impairment of secretory pathway in Leishmania donovani and reduced parasite survival in macrophages.
    Debrabant A; Lee N; Pogue GP; Dwyer DM; Nakhasi HL
    Int J Parasitol; 2002 Oct; 32(11):1423-34. PubMed ID: 12350377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
    Roy S; Mandal C
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response.
    Gupta P; Giri J; Srivastav S; Chande AG; Mukhopadhyaya R; Das PK; Ukil A
    FASEB J; 2014 Apr; 28(4):1756-68. PubMed ID: 24391131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection.
    Bhattacharjee S; Bhattacharjee A; Majumder S; Majumdar SB; Majumdar S
    J Antimicrob Chemother; 2012 Aug; 67(8):1905-14. PubMed ID: 22589456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phagocytosis of hemozoin by RAW 264.7 cells, but not THP-1 cells, promotes infection by Leishmania donovani with a nitric oxide-independent mechanism.
    van den Bogaart E; Mens PF; Adams ER; Grobusch MP; Schallig HDFH
    Parasitol Int; 2017 Apr; 66(2):196-206. PubMed ID: 27623326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twin Attributes of Tyrosyl-tRNA Synthetase of Leishmania donovani: A HOUSEKEEPING PROTEIN TRANSLATION ENZYME AND A MIMIC OF HOST CHEMOKINE.
    Anand S; Madhubala R
    J Biol Chem; 2016 Aug; 291(34):17754-71. PubMed ID: 27382051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A.1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase.
    Balaraman S; Singh VK; Tewary P; Madhubala R
    Mol Biochem Parasitol; 2005 Jan; 139(1):117-27. PubMed ID: 15610826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a RAC/AKT-like gene in Leishmania parasites as a putative therapeutic target in leishmaniasis.
    Varela-M RE; Ochoa R; Muskus CE; Muro A; Mollinedo F
    Parasit Vectors; 2017 Oct; 10(1):458. PubMed ID: 29017516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation of dual specificity phosphatase 4 during visceral leishmaniasis.
    Parveen S; Chowdhury AR; Jawed JJ; Majumdar SB; Saha B; Majumdar S
    Microbes Infect; 2018 Feb; 20(2):111-121. PubMed ID: 29133249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
    Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
    Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Parmar N; Chandrakar P; Vishwakarma P; Singh K; Mitra K; Kar S
    J Immunol; 2018 Aug; 201(3):957-970. PubMed ID: 29907707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.